Aquestive Therapeutics, Inc. Warrants and Rights Outstanding
Aquestive Therapeutics, Inc. (AQST) had Warrants and Rights Outstanding of $916.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-08-11
- 2026-06-30: Warrants and Rights Outstanding $916.00K.
- 2026-03-31: Warrants and Rights Outstanding $916.00K.
- 2022-06-30: Warrants and Rights Outstanding $5.87M.
- 2018-12-31: Warrants and Rights Outstanding $0.00.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2026-06-30 | $916.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $916.00K 10-Q · filed 2026-05-13 |
| 2022-06-30 | $5.87M 10-Q · filed 2026-08-11 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-05 |
| 2018-06-30 | $8.84M 10-Q · filed 2018-09-04 |
| 2017-12-31 | $7.67M 10-Q · filed 2019-11-05 |
| 2016-12-31 | $6.55M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |